FTRE: Fortrea Holdings Inc. filed SEC Form 8-K: Leadership Update
Stocks in this Quantisnow insightHealth Care
Historical context for FTRE
Across the 25 sessions after earlier FTRE headlines, the stock closed higher 17 times and lower 8 times, with a median move of 2.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | FTRE | SPY |
|---|---|---|---|
| Sep 2, 2026 | Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials | +3.6% | +0.4% |
| Jul 29, 2026 | Fortrea Reports Second Quarter 2026 Results | -1.4% | -1.5% |
| Jul 13, 2026 | Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call | +0.6% | -0.8% |
| Jun 26, 2026 | Fortrea Names Jason Knoblauch as Chief Financial Officer | -0.3% | -0.7% |
| Jun 11, 2026 | Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | +3.2% | +1.7% |
| Jun 3, 2026 | Fortrea to Attend Jefferies Global Healthcare Conference | +1.8% | -0.7% |
Quantisnow market dataNASDAQ
FTRE
Fortrea Holdings Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical Specialities
Get push alerts for FTRE
Full FTRE profile on Quantisnow Follow FTRE and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time